EmbryoTrans Biotech ApS — Credit Rating and Financial Key Figures

EmbryoTrans Biotech ApS (CVR number: 36701676) is a company from HALSNÆS. The company recorded a gross profit of 520 kDKK in 2020. The operating profit was -7.2 kDKK, while net earnings were -10.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.6 %, which can be considered poor and Return on Equity (ROE) was -4.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 67.7 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. EmbryoTrans Biotech ApS's liquidity measured by quick ratio was 3.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.